Waterstone
Latest round
- Series C
Last raised
- Nov 2020
Total raised
- $76M
Investors
- 9
About Waterstone
Established in 2009 and based in Wuhan, China. Waterstone is a biotechnology medicine company that focuses on the research and development of molecular medicine and new drugs. It has more than 30 invention patents that have been authorized by China, the United States and Japan. Faming Zhang, the founder and chairman of the company, graduated from Wuhan University, used to work at the Institute of Biophysics, Chinese Academy of Sciences, and is a professor at the School of Pharmacy, Wuhan University. Waterstone cooperated with Harvard University, PKU HEALTHCARE, VIFOR PHARMA, and other universities and institutions. The company has 3 branch offices in Shanghai and Tianmen. Waterstone's main business is the research, development, production, and sales of pharmaceutical intermediates, APIs, and preparations for major diseases such as cancer, NASH, diabetes, and kidney disease. Products include Alogliptin Benzoate, Canagliflozin, and Febuxostat. It has built 4 production lines for polymer drugs from intermediates, and APIs to formulations.
Who invested in Waterstone
9 investors across 3 rounds
See all investors in Waterstone
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Waterstone
Who invested in Waterstone?
Waterstone has 9 investors on record across 3 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Waterstone raised?
Waterstone has raised 3 venture rounds. Sign up free to see how much each round raised and the total.
When did Waterstone last raise money?
Waterstone's most recent round on record is a Series C, in Nov 2020.
What does Waterstone do?
Established in 2009 and based in Wuhan, China.
Where is Waterstone headquartered?
Waterstone is headquartered in Wuhan, China.
Which VCs invest in companies like Waterstone?
Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Hui Hua Fund, Yufu Capital and ICBC Capital Management back pharmaceuticals companies at Waterstone's stage. Their profiles are linked below.
VCs backing pharmaceuticals startups at Series C
Raising like Waterstone? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.